- Home
- CRT vs ICCM Comparison
CRT vs ICCM Comparison
Compare CRT & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CRT | ICCM |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.5M | 45.5M |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRT | ICCM |
|---|---|---|
| Price | $8.08 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 26.6K | ★ 363.1K |
| Earning Date | 03-12-2026 | 11-19-2025 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $5,621,913.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.07 | $0.59 |
| 52 Week High | $13.31 | $1.66 |
Technical Indicators
Market Signals| Indicator | CRT | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 45.41 |
| Support Level | $7.34 | $0.61 |
| Resistance Level | $8.36 | $0.72 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 48.03 | 51.61 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.